Cell2Cure

Making Stem Cells Available for Therapy

Cell2Cure Aps is a clinical stage biotherapeutic company providing easy to use “off-the-shelf” allogeneic adipose tissue derived mesenchymal stromal cells for patients with unmet needs.

The product has demonstrated safety in more than 300 patients and is already in multiple phase I and II generating promising results.

Cell2Cure is a spinout company from the Cardiology Stem Cell Centre, Rigshospitalet, Copenhagen University Hospital, Denmark.

The Company

Cell2Cure ApS is a clinical-stage biotherapeutic company using allogeneic adipose tissue derived mesenchymal stromal cells for clinical cellular therapies. It is a spinout company from Cardiology Stem Cell Centre, Rigshospitalet…

Research, Technology & IP

Cell2Cure are providing stem cell solutions for a market where there is a recognized unmet need for a source of high quality stem cells.

Clinical

Cell2Cure interact actively with hospitals, doctors, research groups and the regulatory agencies to advance clinical programs towards registration and marketing.

INVESTOR & PARTNER

We are looking for financial partners / investors that will join us in the development of our company.

Cell2Cure are seeking partners to exploit the full potential of the C2C-ASC technology, partners that may carry out pre-clinical investigations, clinical studies or introduce / test C2C-ASC in existing stem cell development programs.

If you have a serious interest in exploring partnering opportunities – you may contact Cell2Cure.

Our Vision

Our vision is to make stem cell therapies available as treatment options for patients with unmet needs.

To get there, we invite clinicians and partners to collaborate on clinical projects with our readily available cell therapy product, an ”off-the-shelf” allogenic GMP manufactured product with proven safety and good clinical phase I and II track-record.

WE ENGAGE WITH CLINICALS AND COMMERCIAL PARTNERS WHO SEE AN UNMET NEED

We have a proven track record for successful collaborations with clinicians to provide cell therapy for patients with chronic diseases and limited treatment options.

We also enter sublicensing agreements with commercial partners and have an ongoing collaboration with Endevour Cells Aps.

INFO

Address
Cell2Cure ApS
Kajerødgård 9, 3460 Birkerød, Denmark

CONTACT US

Innobooster grant

SME Instrument grant

This project has received funding from the European Union’s SME Instrument, Horizon 2020 research and innovation programme under grant agreement No [H2020-SMEINST-868284_PRO-SCT]

Grand Solution Grant

Cell2Cure, as part of the consortium Clinical Stem cell Innovation and production Center, CSIC, receives funding from Innovation Fund Denmark.